Equazen® Pro: Medical Food for Managing ADHD Symptoms* Announces National Retail Distribution

RENO, Nev., July 6, 2022 /PRNewswire/ -- Equazen® Pro, the "no prescription needed" medical food clinically shown to improve focus and academic performance within 12 weeks*, gained national distribution through major drug and mass-market retailers, both online and in thousands of in-store locations, in June, 2022. With ADHD (Attention-deficit/hyperactivity disorder) affecting 6.1 million children in the United States and the diagnosis rate up a whopping 42% between 2003 and 2011¹, this condition is a troubling issue for patients, parents, and teachers.

Since ADHD is often associated with impaired omega fatty acid balance, Equazen®️ Pro works by providing an optimal balance of both omega-3 and omega-6 fatty acids for the dietary management of ADHD.*

Backed by 15 years of research and 19 published clinical studies including six clinical trials among kids and teens with ADHD, Equazen® Pro is well established in Europe. With its entry into the US, SFI Health is offering not only easy-to-swallow softgels, but also jelly chews which are appropriate for children aged three and up.

In the US, almost 70% of children with ADHD are on medication² and the number of prescriptions jumped to 41.4 million last year, up 10.4% from 2020.³ "Our purpose in bringing Equazen® Pro to the US is to provide a clinically proven, non-prescription, nutrition solution to help reduce ADHD symptoms. Studies show that Equazen® Pro is safe and effective to use as nutritional support along with common prescription ADHD medications.⁴ What excites us most is advancing options available to parents, patients, and healthcare professionals," says Divya Ramakrishnan, General Manager for Americas at SFI Health.

Equazen® Pro for ADHD Support is available in two easy to use formats, softgels and delicious, fruit-flavored jelly chews. Learn more at www.Equazen.US

Media contact: Media Relations Agency, 952-697-5220

*EQUAZEN® PRO is a medical food to address fatty acid deficiencies common in people with ADHD and some related neurodiverse conditions that cannot be resolved by normal diet modification alone. In clinical trials* among kids and teens with ADHD, the EQUAZEN® PRO formula showed on average significant improvements in focus, attention, academic performance, and balanced mood. USE UNDER MEDICAL SUPERVISION. *19 clinical studies include 6 ADHD clinical trials.

¹ Visser SN, Danielson ML, Bitsko RH, et al. 2003-2011. Journal of the American Academy of Child & Adolescent Psychiatry 2014; 53:34–46.e2
² https://www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivity-disorder-adhd 
³ Walmart, CVS Pharmacies Have Blocked or Delayed Telehealth Adderall Prescriptions - WSJ
⁴Barragán E, Breuer D, Döpfner M. Journal of Attention Disorders. 2017;21(5):433-441.

SOURCE Equazen